Are there any management commentary or guidance updates that address the recent performance decline?

The brief press release does not contain any explicit management commentary or revised outlook that directly addresses the sharp swing from a $4.9 million EBITDA (Q1 2025) to a –$3.2 million EBITDA in the latest quarter, nor does it give a revised guidance horizon. The announcement is limited to raw financial results (net loss $8.3 M, or $0.20 per share, versus a modest profit in the prior quarter). Consequently, investors have no direct insight from management on whether the decline is viewed as a short‑term cycle‑related dip, a result of operational issues, or a longer‑term structural challenge.

From a trading perspective, the lack of guidance adds uncertainty and typically depresses the stock’s near‑term momentum. Technical charts show Conifex (CFF) trading below its 20‑day EMA and holding near the lower Bollinger Band, indicating bearish pressure. Until management provides a clearer narrative—whether via a conference‑call transcript, a management‑discussion‑and‑analysis (MD&A) update, or an updated guidance statement—traders should treat the stock as high‑risk. A prudent approach would be to stay out of new long positions, consider reducing exposure if already held, and watch for the next earnings call or a formal management commentary that could either confirm a deeper earnings‑restructuring plan (potentially a buying opportunity if the outlook improves) or confirm continued weakness (which may prompt further short‑bias positioning).